Home » Cancer Tests » Colon Cancer – Risk of Recurrence

Colon Cancer – Risk of Recurrence

The following test will assess Colon Cancer – Risk of Recurrence

Oncotype DX® Colon Cancer Assay

Test available from: Oncotypeiq

The Oncotype DX® Colon Cancer Assay quantifies recurrence risk in stage II and stage III colon cancer, beyond traditional qualitative measures. This enables an individualized approach to treatment planning. The Oncotype DX test measures a group of cancer genes in the tumor, providing a quantitative Recurrence Score® result beyond traditional measures so physicians and patients can have a more complete discussion of recurrence risk.

The Oncotype DX® Recurrence Score® result, when combined with mismatch repair status and T-stage, provides an individualized, quantitative and reproducible assessment of recurrence risk to help guide treatment decision-making for patients with stage II and stage III colon cancer.

Article source: Oncotypeiq

Updated 2023

Cancer Tests

Please share this page to help others